Search research articles
Contact Us
Filters
Showing results (21-30 of 178) with videos related to
Page
of 18
Sort By:
The Hastings Center Report
|
May 24, 2012
Which orphans will find a home? The rule of rescue in resource allocation for rare diseases
Emily A Largent, Steven D Pearson
Journal of Medical Ethics
|
October 14, 2020
Compensating for research risk: permissible but not obligatory
Holly Fernandez Lynch, Emily A Largent
JAMA Neurology
|
February 19, 2024
Diagnosing Preclinical and Prodromal Neurodegenerative Diseases-The Clinical Is Political
Claire M Erickson, Emily A Largent
Clinical Trials (London, England)
|
December 21, 2018
Making the case for completion bonuses in clinical trials
Emily A Largent, Holly Fernandez Lynch
JAMA Neurology
|
January 4, 2022
Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures Act
Emily A Largent, Angela R Bradbury
Perspectives in Biology and Medicine
|
November 29, 2021
The Legality and Ethics of Mandating COVID-19 Vaccination
Emily A Largent, Franklin G Miller
Yale Journal of Health Policy, Law, and Ethics
|
December 19, 2017
Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward
Emily A Largent, Holly Fernandez Lynch
The Journal of Infectious Diseases
|
May 30, 2020
Paying Participants in COVID-19 Trials
Emily A Largent, Holly Fernandez Lynch
BMJ (Clinical Research Ed.)
|
June 8, 2023
Considering tomorrow's patients in today's drug approvals
Holly Fernandez Lynch, Emily A Largent
The Hastings Center Report
|
April 11, 2021
Public Attitudes toward Consent When Research Is Integrated into Care-Any "Ought" from All the "Is"?
Stephanie R Morain, Emily A Largent
Page
of 18
Search research articles
Search
Showing results (21-30 of 178) with videos related to
Sort By:
Page
of 18
The Hastings Center Report
|
May 24, 2012
Which orphans will find a home? The rule of rescue in resource allocation for rare diseases
Emily A Largent, Steven D Pearson
Journal of Medical Ethics
|
October 14, 2020
Compensating for research risk: permissible but not obligatory
Holly Fernandez Lynch, Emily A Largent
JAMA Neurology
|
February 19, 2024
Diagnosing Preclinical and Prodromal Neurodegenerative Diseases-The Clinical Is Political
Claire M Erickson, Emily A Largent
Clinical Trials (London, England)
|
December 21, 2018
Making the case for completion bonuses in clinical trials
Emily A Largent, Holly Fernandez Lynch
JAMA Neurology
|
January 4, 2022
Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures Act
Emily A Largent, Angela R Bradbury
Perspectives in Biology and Medicine
|
November 29, 2021
The Legality and Ethics of Mandating COVID-19 Vaccination
Emily A Largent, Franklin G Miller
Yale Journal of Health Policy, Law, and Ethics
|
December 19, 2017
Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward
Emily A Largent, Holly Fernandez Lynch
The Journal of Infectious Diseases
|
May 30, 2020
Paying Participants in COVID-19 Trials
Emily A Largent, Holly Fernandez Lynch
BMJ (Clinical Research Ed.)
|
June 8, 2023
Considering tomorrow's patients in today's drug approvals
Holly Fernandez Lynch, Emily A Largent
The Hastings Center Report
|
April 11, 2021
Public Attitudes toward Consent When Research Is Integrated into Care-Any "Ought" from All the "Is"?
Stephanie R Morain, Emily A Largent
Page
of 18